Overview (18 Sep 2026)
Parnax Lab Ltd
PARNAXLAB
INE383L01019

Pharmaceuticals
1.5

Prev. Close
Previous Close
123.8
Current Close
125.3
Current High
128.05
Current Low
120.4
52 Week High
182
52 Week Low
99.2
Resistance 1
128.76
Resistance 2
132.23
Support 1
121.11
Support 2
113.46
Std Deviation
6.23%
DMA 200
133.16
DMA 50
133.63
DMA 20
128.40
Fundamentals and Ratios
Standalone
Trailing EPS
0.77
Forwad EPS
1.17
Trailing P/E
162.73
Forward P/E
106.79
PEG Ratio
0.74
Mkt. Cap (Cr)
Market Cap (Cr)
143.91
Total Debt(Cr)
Tot. Debt(Cr)
NA
Reserve (Cr)
NA
Book Value
NA
P/BV Ratio
NA
ROCE(%)
N/A
ROE
N/A
Consolidated
Trailing EPS
10.05
Forwad EPS
11.16
Trailing P/E
12.47
Forward P/E
11.23
PEG Ratio
0.84
Mkt. Cap (Cr)
Market Cap (Cr)
143.91
Total Debt(Cr)
Tot. Debt(Cr)
0.00
Reserve (Cr)
Book Value
994.57
P/BV Ratio
0.16
ROCE(%)
N/A
ROE
N/A

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue2.570.252.711.71.976.63
Other Income0.211.760.220.200.192.37
Total Income2.782.012.931.902.158.99
Interest0.000.010.000.020.010.03
Expenditure-1.93-3.28-1.96-1.24-1.80-8.31
PBDT0.000.000.000.000.000.00
Depreciation-0.02-0.02-0.02-0.02-0.02-0.07
PBT0.85-1.280.950.660.310.65
Tax0.000.73-0.24-0.170.000.24
Equity0.000.000.000.000.000.00
OPM32.94-516.1335.1238.9215.967.00
Net Profit0.85-1.280.710.490.240.89
NPM32.94-516.1326.1828.9811.9410
EPS0.74-0.480.620.4300.77
Consolidated
TypeDec-25Sep-25Jun-25Mar-25Dec-24FY24-25
Revenue62.9462.653.3849.0440.22187.74
Other Income0.970.630.190.430.191.68
Total Income63.9163.2353.5649.4640.41189.41
Interest0.001.401.221.281.235.39
Expenditure-59.52-58.03-49.10-45.50-38.96-173.70
PBDT0.000.000.000.000.000.00
Depreciation0.00-2.10-1.94-1.83-1.79-7.38
PBT3.255.214.463.951.4515.67
Tax-0.53-1.58-1.10-1.00-0.24-4.10
Equity0.000.000.000.000.000.00
OPM5.098.238.327.993.588.27
Net Profit2.723.623.282.931.2111.54
NPM4.255.736.115.9236.09
EPS03.152.852.551.0610.05
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings